{
  "paper_metadata": {
    "pmid": "38541013",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR V142I variant, including penetrance data and individual case details."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.424G>A",
      "protein_notation": "p.Val142Ile",
      "genomic_position": "chr18:31598655",
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 666,
        "demographics": "AA patients with heart failure or arrhythmia",
        "phenotype": "ATTR-CM primarily manifesting as cardiac phenotype"
      },
      "penetrance_data": {
        "total_carriers_observed": 18,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 65,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "HF or arrhythmia plus spinal stenosis, bilateral carpal tunnel syndrome, multi/chronic diarrhea, eye disease, and lower extremity numbness.",
          "evidence_sentence": "The TTR V142I homozygote was >65 years and female, with a diagnosis of HF or arrhythmia plus spinal stenosis, bilateral carpal tunnel syndrome, multi/chronic diarrhea, eye disease, and lower extremity numbness."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "uncertain",
          "phenotype_details": "Not specified.",
          "evidence_sentence": "Of the 18 TTR V142I allele carriers, 38.9% were male, and 50% were 65 years of age or older."
        }
      ],
      "functional_data": {
        "summary": "The V142I variant destabilizes TTR tetramers, leading to amyloid fibril formation.",
        "assays": [
          "TaqMan genotyping assay",
          "Sanger sequencing"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "Approximately 2.7% of the patients carried a TTR V142I allele (18/666).",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "No other TTR variants were found in the cohort.",
      "key_quotes": [
        "Despite the high prevalence of the TTR V142I variant in AA, there appears to be a substantial divergence between the number of TTR V142I carriers and diagnosed cases of ATTR-CM.",
        "The allele frequencies of these variants are rare compared to p.Val142Ile (V142I, also referred to as V122I), carried by an estimated >3% of individuals of African American (AA) ancestry."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 2",
      "table_caption": "Demographics and clinical characteristics of patients with heart failure or arrhythmia.",
      "variants_extracted": 1
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding the TTR V142I variant was successfully extracted."
  }
}